<DOC>
	<DOCNO>NCT02210819</DOCNO>
	<brief_summary>Following finding clinical trial drug development , global non-interventional cohort field study investigate rivaroxaban clinical practice condition comparison current standard care patient acute venous thoromboembolism ( VTE ) . The main goal analyze long-term safety use rivaroxaban treatment acute VTE routine clinical practice .</brief_summary>
	<brief_title>Treatment Venous Thromboembolism ( VTE ) With Either Rivaroxaban Current Standard Care Therapy</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Female male patient , &gt; =18 year Diagnosis acute DVT and/or PE , objectively confirm Indication anticoagulation therapy least 12 week Willing participate study available followup Exclusion criterion must read conjunction local product information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Thromboembolism</keyword>
	<keyword>Embolism Thrombosis</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Thrombosis</keyword>
</DOC>